Senores subsidiary completes USFDA inspection for Vadodara facility

Senores Pharmaceuticals Limited has announced the successful completion of a regulatory audit by the United States Food and Drug Administration (USFDA).

The inspection was conducted at the Vadodara manufacturing facility of the company's subsidiary, Apnar Pharma Private Limited, spanning five days from September 7, 2026, to September 11, 2026.

The USFDA concluded the audit with no Good Manufacturing Practice (GMP) observations and one minor procedural observation. Senores Pharmaceuticals confirmed that Apnar Pharma will submit its response to the observation within the stipulated timeframe.

KIMS expands AP footprint with 10-year O&M agreement for Trust Multi Speciality Hospital

Krishna Institute of Medical Sciences Limited has entered into an Operations and Management (O&M) Agreement with Sarvottam Health Care Private Limited (SHPL) to manage and operate "Trust Multi Speciality Hospital," a premier 183-bed healthcare facility in Kakinada, Andhra Pradesh.